Reverse Transcriptase Polymerase Chain Reaction (RTPCR) Molecular Testing

2 Görünümler
administrator
administrator
07/10/23

In this segment, F. Anthony Greco, MD, and Suresh S. Ramalingam, MD, analyze the benefits of conducting reverse transcriptase polymerase chain reaction (RTPCR) molecular tests in oncology.

  • kategori

Daha fazla göster
0 Yorumlar Göre sırala

    Hiçbir yorum bulunamadı

    Facebook Yorumları

    Bir sonraki

    Molecular Alterations and New Drugs in Bile Duct Cancer
    00:11:58
    Molecular Alterations and New Drugs in Bile Duct Cancer
    administrator
    6 Görünümler
    Molecular Testing in Unresectable Biliary Tract Cancer | Daniel Catenacci, MD | ASCO22 GI Updates
    00:01:37
    Molecular Testing in Unresectable Biliary Tract Cancer | Daniel Catenacci, MD | ASCO22 GI Updates
    administrator
    8 Görünümler
    Testing anti-amyloid therapies in preclinical Alzheimer's disease
    00:02:49
    Testing anti-amyloid therapies in preclinical Alzheimer's disease
    administrator
    5 Görünümler
    hATTR amyloidosis: The Importance of Genetic Testing
    00:02:38
    hATTR amyloidosis: The Importance of Genetic Testing
    administrator
    6 Görünümler
    Using AI to predict light chain amyloidosis in patients with MGUS and SMM
    00:02:19
    Using AI to predict light chain amyloidosis in patients with MGUS and SMM
    administrator
    10 Görünümler
    Genetic Testing in hATTR Amyloidosis
    00:07:40
    Genetic Testing in hATTR Amyloidosis
    administrator
    3 Görünümler
    The clinical features of pulmonary light chain amyloidosis
    00:01:09
    The clinical features of pulmonary light chain amyloidosis
    administrator
    5 Görünümler
    Anal HPV: Who should be concerned, what testing is available, and how to prevent anal cancer.
    00:16:12
    Anal HPV: Who should be concerned, what testing is available, and how to prevent anal cancer.
    administrator
    3 Görünümler
    Molecular Classification of Endometrial Cancers : Dr Sudha Murthy
    00:27:47
    Molecular Classification of Endometrial Cancers : Dr Sudha Murthy
    administrator
    2 Görünümler
    Prof Dr Somashekhar S P | Molecular Classification of Endometrial Cancer
    00:24:06
    Prof Dr Somashekhar S P | Molecular Classification of Endometrial Cancer
    administrator
    2 Görünümler
    Molecular Classification of Endometrial Cancers- Foundations and In Practice
    00:41:13
    Molecular Classification of Endometrial Cancers- Foundations and In Practice
    administrator
    6 Görünümler
    Mother shares baby’s cancer story to raise awareness about further testing children for disease
    00:02:05
    Mother shares baby’s cancer story to raise awareness about further testing children for disease
    administrator
    3 Görünümler
    Day 1 - International Paediatric Brain Tumours Course - Neuropathology and Molecular Biology
    05:04:40
    Day 1 - International Paediatric Brain Tumours Course - Neuropathology and Molecular Biology
    administrator
    5 Görünümler
    Recent update on molecular biology and genetics of Ependymomas
    00:23:45
    Recent update on molecular biology and genetics of Ependymomas
    administrator
    6 Görünümler
    Advances in understanding the molecular pathogenesis of CTCL
    00:01:15
    Advances in understanding the molecular pathogenesis of CTCL
    administrator
    4 Görünümler
    New molecular targets for cutaneous T-cell lymphoma therapy
    00:02:03
    New molecular targets for cutaneous T-cell lymphoma therapy
    administrator
    4 Görünümler
    Acute Lymphoblastic Leukemia: Challenges in MRD Testing
    00:05:01
    Acute Lymphoblastic Leukemia: Challenges in MRD Testing
    administrator
    2 Görünümler
    Dr Emine Kilic - Molecular genetics of choroidal melanoma: Impact on prognosis and therapies
    00:32:28
    Dr Emine Kilic - Molecular genetics of choroidal melanoma: Impact on prognosis and therapies
    administrator
    3 Görünümler
    Melanoma: Testing for Immunotherapy-Related Hepatotoxicity
    00:06:08
    Melanoma: Testing for Immunotherapy-Related Hepatotoxicity
    administrator
    2 Görünümler